Oral ibuprofen preparation
An oral ibuprofen preparation which includes ibuprofen, magnesium oxide, and glycyrrhetinic acid and which is highly effective in mitigating the gastric-mucosa-disordering action of ibuprofen. Specifically, the oral ibuprofen preparation contains magnesium oxide in an amount of 0.01-8.0 parts by wei...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Umino, Makoto Yamaguchi, Tomihisa Miyadai, Nobuo |
description | An oral ibuprofen preparation which includes ibuprofen, magnesium oxide, and glycyrrhetinic acid and which is highly effective in mitigating the gastric-mucosa-disordering action of ibuprofen. Specifically, the oral ibuprofen preparation contains magnesium oxide in an amount of 0.01-8.0 parts by weight per part by weight of the ibuprofen and contains glycyrrhetinic acid in an amount of 0.01-0.2 parts by weight per part by weight of the ibuprofen. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2017384442BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2017384442BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2017384442BB23</originalsourceid><addsrcrecordid>eNrjZJDyL0rMUchMKi0oyk9LzVMoKEotSCxKLMnMz-NhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfGOoUYGhubGFiYmJkZOTkbGRCoDADJtJJ4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Oral ibuprofen preparation</title><source>esp@cenet</source><creator>Umino, Makoto ; Yamaguchi, Tomihisa ; Miyadai, Nobuo</creator><creatorcontrib>Umino, Makoto ; Yamaguchi, Tomihisa ; Miyadai, Nobuo</creatorcontrib><description>An oral ibuprofen preparation which includes ibuprofen, magnesium oxide, and glycyrrhetinic acid and which is highly effective in mitigating the gastric-mucosa-disordering action of ibuprofen. Specifically, the oral ibuprofen preparation contains magnesium oxide in an amount of 0.01-8.0 parts by weight per part by weight of the ibuprofen and contains glycyrrhetinic acid in an amount of 0.01-0.2 parts by weight per part by weight of the ibuprofen.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221208&DB=EPODOC&CC=AU&NR=2017384442B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221208&DB=EPODOC&CC=AU&NR=2017384442B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Umino, Makoto</creatorcontrib><creatorcontrib>Yamaguchi, Tomihisa</creatorcontrib><creatorcontrib>Miyadai, Nobuo</creatorcontrib><title>Oral ibuprofen preparation</title><description>An oral ibuprofen preparation which includes ibuprofen, magnesium oxide, and glycyrrhetinic acid and which is highly effective in mitigating the gastric-mucosa-disordering action of ibuprofen. Specifically, the oral ibuprofen preparation contains magnesium oxide in an amount of 0.01-8.0 parts by weight per part by weight of the ibuprofen and contains glycyrrhetinic acid in an amount of 0.01-0.2 parts by weight per part by weight of the ibuprofen.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDyL0rMUchMKi0oyk9LzVMoKEotSCxKLMnMz-NhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfGOoUYGhubGFiYmJkZOTkbGRCoDADJtJJ4</recordid><startdate>20221208</startdate><enddate>20221208</enddate><creator>Umino, Makoto</creator><creator>Yamaguchi, Tomihisa</creator><creator>Miyadai, Nobuo</creator><scope>EVB</scope></search><sort><creationdate>20221208</creationdate><title>Oral ibuprofen preparation</title><author>Umino, Makoto ; Yamaguchi, Tomihisa ; Miyadai, Nobuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2017384442BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Umino, Makoto</creatorcontrib><creatorcontrib>Yamaguchi, Tomihisa</creatorcontrib><creatorcontrib>Miyadai, Nobuo</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Umino, Makoto</au><au>Yamaguchi, Tomihisa</au><au>Miyadai, Nobuo</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Oral ibuprofen preparation</title><date>2022-12-08</date><risdate>2022</risdate><abstract>An oral ibuprofen preparation which includes ibuprofen, magnesium oxide, and glycyrrhetinic acid and which is highly effective in mitigating the gastric-mucosa-disordering action of ibuprofen. Specifically, the oral ibuprofen preparation contains magnesium oxide in an amount of 0.01-8.0 parts by weight per part by weight of the ibuprofen and contains glycyrrhetinic acid in an amount of 0.01-0.2 parts by weight per part by weight of the ibuprofen.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2017384442BB2 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Oral ibuprofen preparation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T05%3A27%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Umino,%20Makoto&rft.date=2022-12-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2017384442BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |